<DOC>
	<DOCNO>NCT00647205</DOCNO>
	<brief_summary>The aim study estimate usefulness QuantiFERON TB Gold In-Tube® T-SPOT.TB® diagnosis latent tuberculosis HIV infect antiretroviral naive patient : 80 originate low TB prevalence country , without active TB ; 80 HIV infect antiretroviral naïve patient originate high TB prevalence country , without active TB , 40 HIV infect patient active TB 40 HIV negative patient active TB .</brief_summary>
	<brief_title>Evaluation 2 Interferon γ Assays Diagnosis Latent Tuberculosis HIV-infected Patients.ANRS EP 40 QUANTI SPOT</brief_title>
	<detailed_description>The aim study estimate usefulness QuantiFERON TB Gold In-Tube T-SPOT.TB diagnosis latent tuberculosis population . Concordance TST , QuantiFERON TB Gold T-SPOT.TB assess patient different risk TB , transversal study . This study include 240 patient 2 year : 80 HIV infect antiretroviral naïve patient originate low TB prevalence country , without active TB ( 40 patient CD4 cell count &gt; 350/mm3 , 40 CD4 &lt; 350/mm3 ) , 80 HIV infect antiretroviral naïve patient originate high TB prevalence country , without active TB , 40 HIV infect patient active TB 40 HIV negative patient active TB . TST 2 blood interferon gamma assay compare accord level risk . The improvement latent TB diagnosis HIV infect patient may lead initiation TB prophylaxis decrease incidence life threaten disease .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>sign inform consent adult pregnant clinical examination medical questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Interferon , gamma</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>Tuberculosis</keyword>
</DOC>